Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 or 9.4 or by SELEXIS pursuant to Article 9.2 or 9.3, all and any rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the licenses which have become perpetual pursuant to Article 3.1.3.
Appears in 7 contracts
Samples: Commercial License Agreement, Commercial License Agreement, Commercial License Agreement (Oncobiologics, Inc.)
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.29.2 or 9.4, all and any rights and licenses granted under this Agreement shall terminate upon termination of this Agreement except for the licenses which have become perpetual pursuant to Article 3.1.3. 9.3 or 9.4 or In the event of a termination of this Agreement by SELEXIS pursuant to Article 9.2 or 9.3, all and any rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, Agreement except for the licenses which have become perpetual pursuant to Article 3.1.3.
Appears in 3 contracts
Samples: Commercial License Agreement (Opthea LTD), Commercial License Agreement (Opthea LTD), Commercial License Agreement (Opthea LTD)
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 Section 7,2, 7.3, or 9.4 7.4 or by SELEXIS Selexis pursuant to Article 9.2 Sections 7.2 or 9.37.3, all and any the rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the other than those licenses which have become perpetual pursuant to Article 3.1.3as described in Sections 3.1,3 and 7.1.
Appears in 2 contracts
Samples: Commercial License Agreement (Coherus BioSciences, Inc.), Commercial License Agreement (Coherus BioSciences, Inc.)
Termination of Licenses. In the event of expiration of this Agreement pursuant to Section 2.3 or a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 Section 8.2 or 9.4 8.4 or by SELEXIS Selexis pursuant to Article 9.2 Sections 8.2 or 9.38.3, all and any the rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the licenses which have become perpetual pursuant to Article 3.1.3terminate.
Appears in 2 contracts
Samples: Research License Agreement (Oncobiologics, Inc.), Research License Agreement (Oncobiologics, Inc.)
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 Section 7.2, 7.3, or 9.4 7.4 or by SELEXIS Selexis pursuant to Article 9.2 Sections 7.2 or 9.37.3, all and any the rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the other than those licenses which have become perpetual pursuant as described in Section 3.1.3. ** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to Article 3.1.3.the omitted portions. C1907v1 20 of 31 Neogenix Oncology
Appears in 2 contracts
Samples: Services Agreement (Neogenix Oncology Inc), Services Agreement (Neogenix Oncology Inc)
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 Section 7.2, 7.3 or 9.4 7.4 or by SELEXIS Selexis pursuant to Article 9.2 Sections 7.2 or 9.37.3, all and any the rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the other than those licenses which have become perpetual pursuant to Article 3.1.3as described in Sections 3.1.3 and 7.1.
Appears in 2 contracts
Samples: Commercial License Agreement (Coherus BioSciences, Inc.), Commercial License Agreement (Coherus BioSciences, Inc.)
Termination of Licenses. In the event of a Upon termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 under Section 13.2, 13.3 or 9.4 or by SELEXIS pursuant to Article 9.2 or 9.313.4, all and any rights and licenses granted under this Agreement (other than the license set forth in Section 4.1) shall terminate upon termination as of this Agreement, except for the licenses which have become perpetual pursuant to Article 3.1.3effective date of such termination.
Appears in 2 contracts
Samples: Exclusive Option and License Agreement (Yumanity Therapeutics, Inc.), Exclusive Option and License Agreement (Yumanity Therapeutics, Inc.)
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 9.2 or 9.4 or by SELEXIS pursuant to Article 9.2 or 9.3, all and any rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, Agreement except for the licenses which have become perpetual pursuant to Article 3.1.3.
Appears in 1 contract
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 or 9.4 Section 7.4 or by SELEXIS Selexis pursuant to Article 9.2 Sections 7.2 or 9.37.3, all and any the rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the other than those licenses which have become perpetual pursuant to Article as described in Section 3.1.3.
Appears in 1 contract
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 Section 7.2, 7.3, or 9.4 7.4 or by SELEXIS Selexis pursuant to Article 9.2 Sections 7.2 or 9.37.3, all and any the rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the other than those licenses which have become perpetual pursuant as described in Section 3.1.3. ** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to Article 3.1.3the omitted portions.
Appears in 1 contract
